- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
New nano-material kills antibiotic-resistant bacteria
Doctors are not well armed in the fight against antibiotic-resitant bacteria. It is very difficult - or, in the worst case, impossible - to fight such infections. A team of researchers in Münster has now developed a unique nano-material that kills antibiotic-resitant bacteria.
Researchers from Münster University and CeNTech (Center for NanoTechnology) were involved in the work, with Prof. Luisa De Cola leading the chemists and Prof. Berenike Maier heading the biologists. "Our results are a premiere. For the first time we have shown that it is possible to equip nano-particles with the following three functions: the particles adhere specifically to bacteria, mark them and then kill them off," says Dr. Cristian Strassert from the Physical Institute at WWU, who led the work on the study.
The starting material used by the researchers is so-called zeolite-L-nano-crystals. In a simple, inexpensive process these nano-particles are provided with a component which enables the particles to adhere to the surface of the bacteria. In addition, the particles are equipped with a colourant which glows green under a fluorescence microscope and makes the bacteria visible.
The effectiveness of the nano-particles is based on the "photodynamic therapy" method, whereby exposure to light sets off a reaction which kills the bacteria cells. The researchers also tack a third material on to the nano-crystals which is activated by red light and produces certain aggressive oxygen molecules. These oxygen molecules - "singlet oxygen" - start a chain reaction which destroys the bacteria cell.
The new nano-particles have hitherto adhered, through electrostatic interplay, to types of bacteria with certain surface properties ("gram-negativ"). The researchers are now working on making binding to other types of bacteria possible and increasing the binding specifity. In future the method could then be used to target certain bacteria in localised illnesses.
"Moreover," says Strassert, "we are looking at whether the method could be used not only to fight antibiotic-resitant bacteria, but also in the treatment of skin cancer." To this end the scientists want to get the nano-particles to bind specifically to cancer cells. "If that succeeds it would be conceivable for the nano-particles to be applied to the skin in future in a cream," says Strassert, describing his vision. "Through exposure to light the particles could then be activated and the cancer cells destroyed."
About Westfälische Wilhelms-Universität Münster
The research profile of the WWU Münster is marked by a considerable number of research focal points of proven excellence – in the humanities (including the Theological Faculties), law, business administration, natural sciences, mathematics and medicine. For example the Leibniz Prize, also known as the "German Nobel Prize", has been awarded to WWU Münster no fewer than four times since 2003. The award-winners are Prof. Hubert Wolf (theology), Prof. Barbara Stollberg-Rilinger (history), Prof. Klaus Mezger (geochemistry) and Prof. Wolfgang Lück (mathematics).
For more information, please click here
Fax: +49(0)251/83-3 20 90
Copyright © Westfälische Wilhelms-Universität MünsterIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Abalonyx launches Reduced Graphene Oxide Product: Abalonyx has successfully scaled up production of thermally reduced graphene oxide (rGO) in its Tofte, Norway, production facility. This product is now offered to customers in Kg-quantities May 10th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 10th, 2016
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Doubling down on Schrödinger's cat May 27th, 2016